IFNG and colitis: The use of PD-L1 blocking mAb in this model prevented the development of experimental colitis in association with the decreased expansion of pathogenic T cells and downregulated inflammatory cytokine production (i.e., IFN-γ, TNF-α) by lamina propria CD4+ T cells [67].